https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-12-01 / Hepatogastroenterology 2007 Dec;54(80):2272-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-12-01 / Hepatogastroenterology 2007 Dec;54(80):2272-52007-12-01 00:00:002007-12-01 00:00:00Experimental evidence for the efficacy of combined therapy of CPT-11 and hyperthermia for squamous cell carcinoma of the esophagus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-08 / J. Invest. Dermatol. 2008 Apr;128(4):949-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-08 / J. Invest. Dermatol. 2008 Apr;128(4):949-562007-11-08 00:00:002007-11-08 00:00:00Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-82007-11-01 00:00:002019-02-15 08:39:22Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-24 / Cancer Sci. 2007 Dec;98(12):1930-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-24 / Cancer Sci. 2007 Dec;98(12):1930-52007-09-24 00:00:002019-02-15 08:48:20Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc(Min/+) mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-09-01 / Int J Hyperthermia 2007 Sep;23(6):513-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-09-01 / Int J Hyperthermia 2007 Sep;23(6):513-272007-09-01 00:00:002019-02-15 08:39:23Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-15 / Cancer Res. 2007 Aug;67(16):7798-806
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-15 / Cancer Res. 2007 Aug;67(16):7798-8062007-08-15 00:00:002019-02-15 08:48:34Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):451-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):451-62007-08-01 00:00:002019-02-15 10:00:36Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):431-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):431-422007-08-01 00:00:002007-08-01 00:00:00Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-292007-08-01 00:00:002007-08-01 00:00:00Benefits of superficial hyperthermia treatment planning: five case studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-06-01 / Int. J. Cancer 2007 Jun;120(11):2418-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-06-01 / Int. J. Cancer 2007 Jun;120(11):2418-252007-06-01 00:00:002019-02-15 08:49:59Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
